Literature DB >> 33503905

Summary of Natural Products Ameliorate Concanavalin A-Induced Liver Injury: Structures, Sources, Pharmacological Effects, and Mechanisms of Action.

Sabrin R M Ibrahim1, Alaa Sirwi2, Basma G Eid3, Shaimaa G A Mohamed4, Gamal A Mohamed2,5.   

Abstract

Liver diseases represent a threat to human health and are a significant cause of mortality and morbidity worldwide. Autoimmune hepatitis (AIH) is a progressive and chronic hepatic inflammatory disease, which may lead to severe complications. Concanavalin A (Con A)-induced hepatic injury is regarded as an appropriate experimental model for investigating the pathology and mechanisms involved in liver injury mediated by immune cells as well as T cell-related liver disease. Despite the advances in modern medicine, the only available strategies to treat AIH, include the use of steroids either solely or with immunosuppressant drugs. Unfortunately, this currently available treatment is associated with significant side-effects. Therefore, there is an urgent need for safe and effective drugs to replace and/or supplement those in current use. Natural products have been utilized for treating liver disorders and have become a promising therapy for various liver disorders. In this review, the natural compounds and herbal formulations as well as extracts and/or fractions with protection against liver injury caused by Con A and the underlying possible mechanism(s) of action are reviewed. A total of 53 compounds from different structural classes are discussed and over 97 references are cited. The goal of this review is to attract the interest of pharmacologists, natural product researchers, and synthetic chemists for discovering novel drug candidates for treating immune-mediated liver injury.

Entities:  

Keywords:  autoimmune hepatitis; concanavalin A; drug discovery; inflammation; liver diseases; mechanism of action; natural products

Year:  2021        PMID: 33503905      PMCID: PMC7910830          DOI: 10.3390/plants10020228

Source DB:  PubMed          Journal:  Plants (Basel)        ISSN: 2223-7747


  91 in total

1.  Platycodin D2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice.

Authors:  Yong Xie; Shu-Wang He; Hong-Xiang Sun; Duo Li
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

2.  Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25.

Authors:  Yuanyue Zhang; Lingyun Li; Chang Qi; Shuyao Hua; Xiaoyuan Fei; Feili Gong; Min Fang
Journal:  Biomed Pharmacother       Date:  2018-12-12       Impact factor: 6.529

3.  Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist.

Authors:  R A Roth; D J Cassell; B A Maddux; I D Goldfine
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

4.  Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression.

Authors:  Chuan-tao Tu; Bing Han; Qun-yan Yao; Yi-an Zhang; Hong-chun Liu; Shun-cai Zhang
Journal:  Int Immunopharmacol       Date:  2011-12-02       Impact factor: 4.932

Review 5.  Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe.

Authors:  Xiaofei Fan; Lin Lin; Binxin Cui; Tianming Zhao; Lihong Mao; Yan Song; Xiaoyu Wang; Hongjuan Feng; Yu Qingxiang; Jie Zhang; Kui Jiang; Xiaocang Cao; Bangmao Wang; Chao Sun
Journal:  Pharmacol Res       Date:  2020-05-23       Impact factor: 7.658

6.  Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression.

Authors:  Chuan-tao Tu; Bing Han; Hong-chun Liu; Shun-cai Zhang
Journal:  Mol Cell Biochem       Date:  2011-06-22       Impact factor: 3.396

7.  Protective effect of Yiguanjian decoction against DNA damage onzzm321990concanavalin A-induced liver injury mice model.

Authors:  Mengxi Tian; Wenlan Liu; Hongjie You; Qingzhou Zhao; Luodan Ouyang; Biane Gao; Xin Zhang; Niancong Che
Journal:  J Tradit Chin Med       Date:  2016-08       Impact factor: 0.848

8.  Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells.

Authors:  Bibhas Roy; Arup K Pattanaik; Joyjyoti Das; Sujit K Bhutia; Birendra Behera; Prashant Singh; Tapas K Maiti
Journal:  Chem Biol Interact       Date:  2014-01-13       Impact factor: 5.192

9.  Protective effect of galangin in Concanavalin A-induced hepatitis in mice.

Authors:  Qingqiong Luo; Liping Zhu; Jieying Ding; Xing Zhuang; Lili Xu; Fuxiang Chen
Journal:  Drug Des Devel Ther       Date:  2015-06-10       Impact factor: 4.162

10.  Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway.

Authors:  Tong Liu; Yujing Xia; Jingjing Li; Sainan Li; Jiao Feng; Liwei Wu; Rong Zhang; Shizan Xu; Keran Cheng; Yuqing Zhou; Shunfeng Zhou; Weiqi Dai; Kan Chen; Fan Wang; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Mediators Inflamm       Date:  2016-05-16       Impact factor: 4.711

View more
  2 in total

1.  Concanavalin A promotes angiogenesis and proliferation in endothelial cells through the Akt/ERK/Cyclin D1 axis.

Authors:  Jing-Zhou Li; Xiao-Xia Zhou; Wei-Yin Wu; Hai-Feng Qiang; Guo-Sheng Xiao; Yan Wang; Gang Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 2.  The Combination of Tradition and Future: Data-Driven Natural-Product-Based Treatments for Parkinson's Disease.

Authors:  Zhijun Miao; Jinwei Bai; Li Shen; Rajeev K Singla
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.